Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $595.2500 (0.94%) ($595.2500 - $595.2500) on Fri. Jul. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.05% (three month average) | RSI | 59 | Latest Price | $595.2500(0.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 3.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) DIA(38%) IWD(35%) SPLV(34%) SPY(34%) | Factors Impacting REGN price | REGN will decline at least -1.025% in a week (0% probabilities). VIXM(-10%) TBT(-9%) UUP(-6%) VXX(-1%) SHY(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.025% (StdDev 2.05%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $595.97(-0.12%) | 10 Day Moving Average | $595.66(-0.07%) | 20 Day Moving Average | $588.98(1.06%) | To recent high | -19.4% | To recent low | 8.7% | Market Cap | $63.114b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |